Ann: Two key treatment centres treat first patients with OncoSil, page-7

Just open the playbook and go back to Resapp.

all the while as big Pfizer was doing due diligence since December 2021, the share price declined and declined further and hit 4c,

this went on for a few months, until after three months finally the news got out and it was announced with a big bang that Resapp had a partner

all this time while Pfizer was already walking the corridors at Resapp, all the little shareholders were stressed, and SP was trading at rock bottom

if you were still shareholder at four cents you were then rewarded with 20.5 cents buy out, that's five bags

and that CR that everyone had anticipated .... never came ---- even though the tin was empty, as Pfizer gave them free money

here is for hoping

I do not think it will play out exactly like this but I have hope for a good solution

4c right now is hurtful